欧州連合 - ノルウェー語 - EMA (European Medicines Agency)

biomarin international limited - sapropterin dihydrochloride - phenylketonurias - andre alimentary tract and metabolism products, - kuvan er indisert for behandling av hyperfenylalaninemi (hpa) hos voksne og pediatriske pasienter i alle aldre med fenylketonuri (pku) som har vist seg å være responsiv overfor slik behandling. kuvan er også angitt for behandling av hyperphenylalaninaemia (hpa) i voksne og paediatric pasienter i alle aldre med tetrahydrobiopterin (bh4) mangel som har vist seg å være lydhør for slik behandling.

ノルウェー - ノルウェー語 - Statens legemiddelverk

aspen pharma trading limited - merkaptopurin - tablett - 50 mg

欧州連合 - ノルウェー語 - EMA (European Medicines Agency)

dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurias - andre alimentary tract and metabolism products, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

ノルウェー - ノルウェー語 - Statens legemiddelverk

teva gmbh - sapropterindihydroklorid - oppløselig tablett - 100 mg

ノルウェー - ノルウェー語 - Statens legemiddelverk

baxter medical ab - fibrinogen, humant / aprotinin / trombin, humant / kalsiumkloriddihydrat - oppløsning til vevslim

ノルウェー - ノルウェー語 - Statens legemiddelverk

aspen pharma trading limited - azatioprin - tablett, filmdrasjert - 50 mg

ノルウェー - ノルウェー語 - Statens legemiddelverk

aspen pharma trading limited - azatioprin - tablett, filmdrasjert - 25 mg

ノルウェー - ノルウェー語 - Statens legemiddelverk

cheplapharm arzneimittel gmbh - meflokinhydroklorid - tablett - 250 mg

ノルウェー - ノルウェー語 - Statens legemiddelverk

baxter medical ab - fibrinogen, humant / aprotinin / trombin, humant / kalsiumklorid - oppløsning til vevslim - / 3000 kiu/ ml / 500 ie/ ml / 40 mikromol/ ml

欧州連合 - ノルウェー語 - EMA (European Medicines Agency)

swedish orphan biovitrum international ab - nitisinone - tyrosinemias - andre alimentary tract and metabolism products, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).